BBOT

Quote

Short

News

Articles

Message Board

BridgeBio Oncology Therapeutics Inc. (NASDAQ : BBOT ) News

BridgeBio Oncology Therapeutics Inc. (NASDAQ: BBOT) News Releases

BBOT News Releases

May 12, 2026 05:12:35 pm

SeekingAlpha

BridgeBio Oncology Therapeutics, Inc. GAAP EPS of -$526.11

May 12, 2026 05:03:31 pm

GlobeNewswire

BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress

April 22, 2026 04:05:00 pm

GlobeNewswire

BBOT Presents Preclinical Data Demonstrating pan-KRAS Inhibitor BBO-11818 Has Robust Anti-Tumor Activity in KRAS-Mutant Preclinical Models at the AACR Annual Meeting 2026

April 22, 2026 09:13:30 am

SeekingAlpha

BridgeBio Oncology Therapeutics appoints new CEO and COO

April 22, 2026 09:00:00 am

GlobeNewswire

BBOT Announces the Appointment of Pedro J. Beltran, PhD, as Chief Executive Officer, Idan Elmelech as Chief Operating Officer, and Neil Kumar, PhD, as Executive Chairman

April 21, 2026 05:30:00 pm

GlobeNewswire

BBOT Presents Preclinical Data Showing RAS:PI3K? Breaker BBO-10203 Inhibits PI3K?/AKT Signaling in HER2AMP Models at the AACR Annual Meeting 2026

April 21, 2026 11:39:50 am

SeekingAlpha

BridgeBio Oncology Therapeutics: Poised To Bank On The KRAS Revolution

April 20, 2026 04:42:10 pm

SeekingAlpha

BridgeBio Oncology rises on Fast Track status for pancreatic cancer asset

April 20, 2026 04:06:48 pm

GlobeNewswire

BBOT Granted U.S. FDA Fast Track Designation for BBO-11818 for the Treatment of Adult Patients with Advanced KRAS-Mutant Pancreatic Ductal Adenocarcinoma

March 18, 2026 04:05:00 pm

GlobeNewswire

BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account